SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-248344
Filing Date
2021-08-17
Accepted
2021-08-17 07:00:40
Documents
14
Period of Report
2021-08-17
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d111789d8k.htm   iXBRL 8-K 25102
2 EX-99.1 d111789dex991.htm EX-99.1 14150
6 GRAPHIC g111789g0817061340447.jpg GRAPHIC 3059
  Complete submission text file 0001193125-21-248344.txt   176091

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA grts-20210817.xsd EX-101.SCH 2918
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE grts-20210817_lab.xml EX-101.LAB 18887
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE grts-20210817_pre.xml EX-101.PRE 11877
7 EXTRACTED XBRL INSTANCE DOCUMENT d111789d8k_htm.xml XML 3462
Mailing Address 5959 HORTON STREET, SUITE 300 EMERYVILLE CA 94608
Business Address 5959 HORTON STREET, SUITE 300 EMERYVILLE CA 94608 (510) 871-6100
Gritstone bio, Inc. (Filer) CIK: 0001656634 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38663 | Film No.: 211180886
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences